Search

Your search keyword '"Carteolol"' showing total 10 results
Start Over Descriptor "Carteolol" Publication Type News
10 results on '"Carteolol"'

1. 'Tesofensine And Beta Blocker Combination Formulations' in Patent Application Approval Process (USPTO 20200129478)

Subjects
Eating disorders, Antihypertensive agents, Adrenergic beta-antagonists, Type 2 diabetes, Povidone -- Intellectual property, Antiangina agents, Aliphatic amines -- Intellectual property, Antiarrhythmia agents -- Intellectual property, Obesity, Nebivolol, Bucindolol, Carteolol, Pindolol, Oxprenolol, Penbutolol, Esmolol, Editors, Health
Abstract

2020 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- A patent application by the inventors NIELSEN, Peter G. (Vaerlose, DK); THOMSEN, Mikael [...]

Published
2020

2. 'Low-Dose Brimonidine Combinations And Uses Thereof' in Patent Application Approval Process (USPTO 20200108064)

Subjects
Patient compliance, Nonsteroidal anti-inflammatory agents, Fluocinolone, Tafluprost, Netarsudil -- Intellectual property, Macular degeneration, Ophthalmic agents -- Intellectual property, Bevacizumab -- Intellectual property, Latanoprostene bunod -- Intellectual property, Adalimumab -- Intellectual property, Glaucoma, Olopatadine -- Intellectual property, Antihistamines -- Intellectual property, Levocabastine, Brimonidine, Desloratadine, Diseases, Emedastine, Tolmetin, Diflunisal, Editors, Levocetirizine, Brinzolamide, Brompheniramine, Allergy, Ranibizumab, Oxaprozin, Uveitis, Cyproheptadine, Bimatoprost, Clemastine, Carbinoxamine, Aflibercept, Carteolol, Sulindac, Immunotherapy, Health
Abstract

2020 APR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent application by the inventor Horn, Gerald (Deerfield, IL), filed on December 3, 2019, [...]

Published
2020

3. 'Agent For Treating Or Preventing Glaucoma Including A Sulfonamide Compound And Another Drug' in Patent Application Approval Process (USPTO 20200085804)

Subjects
Santen Pharmaceutical Company Ltd. -- Intellectual property, Ophthalmic agents, Pharmaceutical industry -- Intellectual property, Drug approval, Sulfonamides, Tafluprost, Glaucoma -- Prevention, Eye diseases, Bimatoprost, Brinzolamide, Carteolol, Travoprost, Editors, Central nervous system, Diseases, Health
Abstract

2020 APR 6 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- A patent application by the inventors KIRIHARA, Tomoko (Ikoma-shi, JP); SHIMAZAKI, [...]

Published
2020

4. Patent Application Titled 'Pharmacotherapy For Preventing Or Treating Glaucoma' Published Online (USPTO 20200038397)

Subjects
Kowa Company Ltd. -- Intellectual property, Ophthalmic agents, Pharmaceutical industry -- Intellectual property, Tafluprost, Glaucoma, Bimatoprost, Carteolol, Travoprost, Editors, Diseases, Business, Health
Abstract

2020 FEB 28 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2020

5. Patent Issued for Tesofensine And Beta Blocker Combination Formulations (USPTO 10,537,551)

Subjects
Eating disorders, Antihypertensive agents, Adrenergic beta-antagonists, Type 2 diabetes, Povidone -- Intellectual property, Antiangina agents, Aliphatic amines -- Intellectual property, Antiarrhythmia agents -- Intellectual property, Obesity, Nebivolol, Bucindolol, Carteolol, Pindolol, Oxprenolol, Penbutolol, Esmolol, Editors, Health
Abstract

2020 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2020

6. Patent Issued for Crystalline Form Of Benzylbenzene SGLT2 Inhibitor (USPTO 10,533,032)

Subjects
Antihypertensive agents, Tezosentan -- Intellectual property, Angiotensin II receptor blockers, Oxcarbazepine, Hypoglycemic agents, Perindopril, Clopidogrel -- Intellectual property, Midostaurin -- Intellectual property, Cilostazol -- Intellectual property, Lofexidine -- Intellectual property, Torsemide -- Intellectual property, Adrenergic beta-antagonists, Type 2 diabetes, Thiazides -- Intellectual property, Calcium channel blockers -- Intellectual property, Antiarrhythmia agents -- Intellectual property, Anopheles, Ambrisentan, Olmesartan medoxomil, Liraglutide, Methyclothiazide, Obesity, Alogliptin, Nebivolol, Exenatide, Eprosartan, Lercanidipine, Penbutolol, Esmolol, Editors, Hydrochlorothiazide, Indapamide, Saxagliptin, Valsartan, Trichlormethiazide, Sitagliptin, Sitaxsentan, Pindolol, Hydroflumethiazide, Omapatrilat, Telmisartan, Fosinopril, Carteolol, Miglitol, Nisoldipine, Bosentan, Bepridil, Health
Abstract

2020 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity & Diabetes Week -- Theracos Sub LLC (Marlborough, Massachusetts, United States) has been issued patent number 10,533,032, [...]

Published
2020

7. 'Methods And Compositions Involving (S)-Bucindolol' in Patent Application Approval Process (USPTO 20190358204)

Subjects
Antihypertensive agents -- Methods, Valsartan -- Methods, Adrenergic beta-antagonists -- Methods, Type 2 diabetes -- Methods, Antiangina agents -- Methods, Eprosartan -- Intellectual property -- Methods, Antiarrhythmia agents -- Intellectual property -- Methods, Biotechnology, Pindolol, Oxprenolol, Pharmacology, Nebivolol, Bucindolol, Fosinopril, Carteolol, Biological products industry, Penbutolol, Esmolol, Editors, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2019 DEC 18 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- A patent application by the inventors Bristow, Michael R. (Englewood, CO); Port, Jonathan D. (Denver, [...]

Published
2019

8. 'Compositions For The Treatment Of Hypertension' in Patent Application Approval Process (USPTO 20190314383)

Subjects
Antihypertensive agents, Angiotensin II receptor blockers, Hypertension, Adrenergic beta-antagonists, Angiotensin II -- Intellectual property, Antiangina agents, Thiazides -- Intellectual property, Calcium channel blockers -- Intellectual property, Antiarrhythmia agents -- Intellectual property, Mortality, Levobetaxolol, Methyclothiazide, Nebivolol, Eprosartan, Lercanidipine, Penbutolol, Clevidipine, Esmolol, Editors, Hydrochlorothiazide, Indapamide, Valsartan, Trichlormethiazide, Pindolol, Oxprenolol, Hydroflumethiazide, Telmisartan, Morbidity, Carteolol, Nisoldipine, Polythiazide, Bepridil, Health
Abstract

2019 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- A patent application by the inventors RODGERS, Anthony (Newtown NSW, AU); CHOW, Clara (Sydney NSW, [...]

Published
2019

9. Reports Outline Chirality Findings from Y. Zhao and Colleagues (Enantioseparation and molecular modeling study of five b-adrenergic blockers on Chiralpak IC column)

Subjects
High performance liquid chromatography, Carteolol, Esmolol, Chromatography, Ethanol, Editors, Liquid chromatography, Health
Abstract

2019 JUN 7 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Science - Chirality. According to news reporting out [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results